-+ 0.00%
-+ 0.00%
-+ 0.00%

Maike Pharmaceutical-B (02335): Phase II clinical trial of MT200605 for acute ischemic stroke (AIS) completed in China

Zhitongcaijing·08/26/2026 14:49:05
Listen to the news

Zhitong Finance App News, Maike Pharmaceutical-B (02335) announced that the phase II clinical trial of MT200605, a drug candidate developed independently by the Group to treat acute ischemic stroke, has been completed. The clinical trial has proven to have significant and robust efficacy advantages and good safety.